In English SILVER SPRING, Md., 24 de mayo de 2023 /PRNewswire-HISPANIC PR WIRE/ — La Administración de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en inglés) aprobó Xacduro (sulbactam inyectable; durlobactam inyectable), un nuevo tratamiento para la neumonía…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.